ESH/LinkedIn
Apr 27, 2026, 15:38
Key Insights from ESHMPN 26 on Advances in MPN Management – ESH
The European School of Haematology (ESH) shared a post on LinkedIn:
“Today’s second ESHMPN 26 session chaired by Jean – Jacques Kiladjian (INSERM) focussed on MPN management.
Marta Sobas (Collegium Medicum Uniwersytetu Mikołaja Kopernika) on the role of interferons on haematological and molecular responses;
- Jennifer O’Sullivan (Guy’s and St Thomas’ NHS Foundation Trust) on new potential trial endpoints;
- Chloé James (CHU de Bordeaux) on how to prevent thrombosis and bleeding in MPN;
- Selected brief oral presentation by Chiara Carretta, (Centro di Medicina Estetica e Rigenerativa) on determinants of JAK inhibitor efficacy in myelofibrosis revealed by Multiomic Single-Cell Analysis
Stay tuned!
For a deeper insight, meet Marta Sobas, Jennifer O’Sullivan, or Chloé James at tomorrow’s meeting the expert session!”

Stay updated with Hemostasis Today.
-
Nov 17, 2026, 01:27X. Long Zheng: Optimizing Treatment in Immune TTP
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C